uric acid has been researched along with Acute Coronary Syndrome in 65 studies
Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.
Acute Coronary Syndrome: An episode of MYOCARDIAL ISCHEMIA that generally lasts longer than a transient anginal episode that ultimately may lead to MYOCARDIAL INFARCTION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The relationship between Serum Uric Acid (UA) and Cardiovascular (CV) diseases has already been extensively evaluated, and it was found to be an independent predictor of all-cause and cardiovascular mortality but also acute coronary syndrome, stroke and heart failure." | 9.41 | The Results of the URRAH (Uric Acid Right for Heart Health) Project: A Focus on Hyperuricemia in Relation to Cardiovascular and Kidney Disease and its Role in Metabolic Dysregulation. ( Agabiti Rosei, E; Angeli, F; Barbagallo, CM; Bernardino, B; Bombelli, M; Borghi, C; Cappelli, F; Casiglia, E; Cianci, R; Ciccarelli, M; Cicero, AFG; Cirillo, M; Cirillo, P; D'Elia, L; Dell'Oro, R; Desideri, G; Facchetti, R; Ferri, C; Galletti, F; Gesualdo, L; Giannattasio, C; Grassi, G; Iaccarino, G; Lippa, L; Mallamaci, F; Maloberti, A; Masi, S; Masulli, M; Mazza, A; Mengozzi, A; Muiesan, ML; Nazzaro, P; Palatini, P; Parati, G; Pauletto, P; Pontremoli, R; Pugliese, NR; Quarti-Trevano, F; Rattazzi, M; Reboldi, G; Rivasi, G; Russo, E; Salvetti, M; Tikhonoff, V; Tocci, G; Ungar, A; Verdecchia, P; Viazzi, F; Virdis, A; Volpe, M, 2023) |
| "Serum gamma-glutamyltransferase (GGT) and uric acid levels measured in patients with acute coronary syndrome without ST segment elevation (NSTEMI) are important in diagnosis and in predicting the prognosis of the disease." | 9.22 | Comparison of the effects of metoprolol or carvedilol on serum gamma-glutamyltransferase and uric acid levels among patients with acute coronary syndrome without ST segment elevation. ( Aşkın, L; Değirmenci, H; Demirelli, S; Karakelleoğlu, Ş; Lazoğlu, Z; Şimşek, Z; Taş, MH; Topçu, S, 2016) |
| "Serum uric acid (SUA) may play a role in heart failure (HF)." | 8.31 | Association between serum uric acid levels and the prevalence of heart failure due to acute coronary syndrome in Chinese hospitalized patients: A cross-sectional study. ( Liang, X; Liu, Y; Rong, D; Sun, G, 2023) |
| "The impact of serum uric acid (sUA) levels on the clinical prognosis and severity of coronary artery disease in patients with acute coronary syndrome (ACS) and hypertension after percutaneous coronary intervention (PCI) is not fully clear." | 8.12 | Impact of serum uric acid levels on the clinical prognosis and severity of coronary artery disease in patients with acute coronary syndrome and hypertension after percutaneous coronary intervention: a prospective cohort study. ( Liu, X; Shao, Y; Song, B; Yu, H; Zhang, S; Zhang, X, 2022) |
| "We focused on the role of Uric Acid (UA) as a possible determinant of Heart Failure (HF) related issues in Acute Coronary Syndromes (ACS) patients." | 8.12 | Uric acid associated with acute heart failure presentation in Acute Coronary Syndrome patients. ( Carugo, S; Castini, D; Centola, M; Ferrante, G; Giannattasio, C; Lucreziotti, S; Maloberti, A; Morici, N; Occhino, G; Oliva, F; Oreglia, J; Persampieri, S; Rebora, P; Sabatelli, L; Sacco, A; Valsecchi, MG; Viola, G, 2022) |
| "This study aims to explore the associations between uric acid (UA) and long-term outcomes among patients with acute coronary syndrome (ACS)." | 8.12 | The Association Between Serum Uric Acid and Mortality in Patients with Acute Coronary Syndrome After Percutaneous Coronary Intervention. ( Horita, Y; Ikeda, M; Kawashiri, MA; Nakahashi, T; Namura, M; Nomura, A; Sakata, K; Tada, H; Takamura, M; Tanaka, Y; Terai, H; Yoshida, T, 2022) |
| "This study evaluated the prognostic power of serum uric acid (UA) in predicting adverse events in elderly acute coronary syndrome (ACS) patients with diabetes mellitus (DM)." | 8.02 | Evaluation of the prognostic ability of serum uric acid for elderly acute coronary syndrome patients with diabetes mellitus: a prospective cohort study. ( Chen, Y; Dong, W; Fu, Z; Guo, J; Jiao, Y; Shen, M; Wang, J; Xi, Q; Xue, H; Yang, X, 2021) |
| "There was an association between hyperuricaemia and in-hospital complications of patients with acute coronary syndrome in comparison with patients with normal serum uric acid levels." | 8.02 | The effect of serum uric acid in hospitalised patients with acute coronary syndrome in Al-Yarmouk Teaching Hospital. ( Abdul Khaliq, SM; Al-Sharifi, AN, 2021) |
| "The prognostic value of serum uric acid (SUA) for incident acute coronary syndrome (ACS) in hypertensive subjects is uncertain." | 7.96 | J-shaped association between serum uric acid and acute coronary syndrome in patients with essential hypertension. ( Chen, CL; Feng, YQ; Huang, JY; Huang, YQ; Liu, L; Shen, G; Yu, YL; Zhang, B, 2020) |
| "Serum uric acid (SUA) level is known to have a prognostic value in patients with acute coronary syndrome (ACS)." | 7.91 | Relation of Elevated Serum Uric Acid Level to Endothelial Dysfunction in Patients with Acute Coronary Syndrome. ( Fujimoto, Y; Kitahara, H; Kobayashi, Y; Nakayama, T; Saito, Y, 2019) |
| "The role of serum uric acid in coronary artery disease has been extensively investigated." | 7.88 | Uric acid levels are associated with endothelial dysfunction and severity of coronary atherosclerosis during a first episode of acute coronary syndrome. ( Alessandrini, M; Barraud, J; Bonello, L; Cautela, J; Fenouillet, E; Fromonot, J; Gaubert, M; Guieu, R; Laine, M; Marlinge, M; Mottola, G; Paganelli, F; Rossi, P; Ruf, J; Thuny, F, 2018) |
| "Elevated serum uric acid (SUA) level is known to be a prognostic factor in patients with acute coronary syndrome (ACS)." | 7.88 | Correlation of Serum Uric Acid Levels with Nonculprit Plaque Instability in Patients with Acute Coronary Syndromes: A 3-Vessel Optical Coherence Tomography Study. ( Lin, L; Wang, N; Yu, B; Zhang, D; Zhang, R, 2018) |
| "Serum uric acid differentiates AIM and UAP patients in hyperuricemic group of acute coronary syndrome." | 7.85 | Serum Uric Acid Could Differentiate Acute Myocardial Infarction and Unstable Angina Pectoris in Hyperuricemic Acute Coronary Syndrome Patients. ( Hasic, S; Jadric, R; Kadic, D; Kiseljakovic, E; Spahic, E, 2017) |
| "Studies have suggested a relationship between higher baseline serum uric acid (sUA) levels and an elevated risk of subsequent ischemic cardiovascular outcomes among acute coronary syndrome (ACS) patients; this relationship may be modified by a clinical history of gout and has not been studied in large patient cohorts." | 7.85 | An examination of the relationship between serum uric acid level, a clinical history of gout, and cardiovascular outcomes among patients with acute coronary syndrome. ( Akerblom, A; Clare, RM; Held, C; Hess, CN; James, S; Keenan, RT; Klein, AB; Mahaffey, KW; Pagidipati, NJ; Roe, MT; Tricoci, P; Wallentin, L; Wojdyla, D, 2017) |
| "Despite the association between uric acid and cardiovascular disease has been known for decades, the prognostic value of serum uric acid (UA) in all clinical manifestations of acute coronary syndrome (ACS), namely ST-elevation myocardial infarction (STEMI), NSTEMI and unstable angina, has not been definitively assessed." | 7.85 | Serum uric acid on admission predicts in-hospital mortality in patients with acute coronary syndrome. ( Angeloni, G; Berteotti, M; Ceriotti, F; Cianflone, D; Cristell, N; Magnoni, M; Mallia, V; Maseri, A; Peretto, G; Vergani, V, 2017) |
| "Although aspirin-clopidogrel combination is more useful for acute coronary syndrome (ACS), the renal safety of this combination had not been established." | 7.83 | Short Communication: Evaluation of nephrotoxicity by aspirin-clopidogrel combination therapy in patients with acute coronary syndrome. ( Baber, M; HamidAkash, MS; Hussain, SB; Irfan, M; Qadir, MI; Rehman, A, 2016) |
| "To assess serum levels and correlation between uric acid (UA) and C-reactive protein (CRP) in acute coronary syndrome (ACS) and apparently healthy individuals." | 7.81 | Positive correlation between uric acid and C-reactive protein serum level in healthy individuals and patients with acute coronary syndromes. ( Hasić, S; Kiseljaković, E; Kulić, M; Resić, H; Spahić, E, 2015) |
| "We evaluated the association of serum uric acid (SUA) level and development of coronary collateral vessels (CCVs) in patients with acute coronary syndrome (ACS)." | 7.78 | High levels of serum uric acid impair development of coronary collaterals in patients with acute coronary syndrome. ( Demircelik, MB; Doger, C; Duran, M; Murat, SN; Ocak, A; Ornek, E; Turfan, M; Vatankulu, MA; Yalcin, AA, 2012) |
| "We aimed to elucidate the relation between serum uric acid (SUA) level and severity of coronary artery disease (CAD) in nondiabetic, nonhypertensive patients (n = 246) with acute coronary syndrome (ACS)." | 7.78 | High levels of serum uric acid predict severity of coronary artery disease in patients with acute coronary syndrome. ( Akpek, M; Duran, M; Elcik, D; Ergin, A; Eryol, NK; Inanc, MT; Kalay, N; Kasapkara, HA; Kaya, MG; Ocak, A; Oguzhan, A; Orscelik, O, 2012) |
| "To evaluate the association of elevation in serum uric acid with the development of coronary artery disease, and to determine the relationship between uric acid and Glu(298) Asp polymorphism of the endothelial nitric oxide synthase (eNOS) gene in acute coronary syndrome (ACS) in the Chinese Han Nationality." | 7.74 | [Association of endothelial nitric oxide synthase gene polymorphism with level of uric acid in serum for acute coronary syndrome]. ( Dai, RJ; He, JC; Li, Q; Liao, JD; Peng, HP; Shi, SL; Wang, ZL; Zhao, YQ, 2007) |
| "This disorder is correlated to a systemic inflammatory response and some biochemical factors." | 5.91 | C-reactive protein and uric acid roles in distinguishing ST-segment elevation myocardial infarction from non-ST-elevation acute coronary syndrome. ( Ghadakkar, N; Golabchi, A; Motedayyen, H; Zamani, B, 2023) |
| "Hyperuricemia was present in 356 (29." | 5.48 | Uric acid is associated with long-term adverse cardiovascular outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention. ( Farhan, S; Freynhofer, MK; Hauser, C; Herman, R; Huber, K; Rohla, M; Tscharre, M; Weiss, TW, 2018) |
| "The relationship between Serum Uric Acid (UA) and Cardiovascular (CV) diseases has already been extensively evaluated, and it was found to be an independent predictor of all-cause and cardiovascular mortality but also acute coronary syndrome, stroke and heart failure." | 5.41 | The Results of the URRAH (Uric Acid Right for Heart Health) Project: A Focus on Hyperuricemia in Relation to Cardiovascular and Kidney Disease and its Role in Metabolic Dysregulation. ( Agabiti Rosei, E; Angeli, F; Barbagallo, CM; Bernardino, B; Bombelli, M; Borghi, C; Cappelli, F; Casiglia, E; Cianci, R; Ciccarelli, M; Cicero, AFG; Cirillo, M; Cirillo, P; D'Elia, L; Dell'Oro, R; Desideri, G; Facchetti, R; Ferri, C; Galletti, F; Gesualdo, L; Giannattasio, C; Grassi, G; Iaccarino, G; Lippa, L; Mallamaci, F; Maloberti, A; Masi, S; Masulli, M; Mazza, A; Mengozzi, A; Muiesan, ML; Nazzaro, P; Palatini, P; Parati, G; Pauletto, P; Pontremoli, R; Pugliese, NR; Quarti-Trevano, F; Rattazzi, M; Reboldi, G; Rivasi, G; Russo, E; Salvetti, M; Tikhonoff, V; Tocci, G; Ungar, A; Verdecchia, P; Viazzi, F; Virdis, A; Volpe, M, 2023) |
| "Serum uric acid (SUA) may play a role in heart failure (HF)." | 4.31 | Association between serum uric acid levels and the prevalence of heart failure due to acute coronary syndrome in Chinese hospitalized patients: A cross-sectional study. ( Liang, X; Liu, Y; Rong, D; Sun, G, 2023) |
| "The impact of serum uric acid (sUA) levels on the clinical prognosis and severity of coronary artery disease in patients with acute coronary syndrome (ACS) and hypertension after percutaneous coronary intervention (PCI) is not fully clear." | 4.12 | Impact of serum uric acid levels on the clinical prognosis and severity of coronary artery disease in patients with acute coronary syndrome and hypertension after percutaneous coronary intervention: a prospective cohort study. ( Liu, X; Shao, Y; Song, B; Yu, H; Zhang, S; Zhang, X, 2022) |
| "We focused on the role of Uric Acid (UA) as a possible determinant of Heart Failure (HF) related issues in Acute Coronary Syndromes (ACS) patients." | 4.12 | Uric acid associated with acute heart failure presentation in Acute Coronary Syndrome patients. ( Carugo, S; Castini, D; Centola, M; Ferrante, G; Giannattasio, C; Lucreziotti, S; Maloberti, A; Morici, N; Occhino, G; Oliva, F; Oreglia, J; Persampieri, S; Rebora, P; Sabatelli, L; Sacco, A; Valsecchi, MG; Viola, G, 2022) |
| "This study evaluated the prognostic power of serum uric acid (UA) in predicting adverse events in elderly acute coronary syndrome (ACS) patients with diabetes mellitus (DM)." | 4.02 | Evaluation of the prognostic ability of serum uric acid for elderly acute coronary syndrome patients with diabetes mellitus: a prospective cohort study. ( Chen, Y; Dong, W; Fu, Z; Guo, J; Jiao, Y; Shen, M; Wang, J; Xi, Q; Xue, H; Yang, X, 2021) |
| "There was an association between hyperuricaemia and in-hospital complications of patients with acute coronary syndrome in comparison with patients with normal serum uric acid levels." | 4.02 | The effect of serum uric acid in hospitalised patients with acute coronary syndrome in Al-Yarmouk Teaching Hospital. ( Abdul Khaliq, SM; Al-Sharifi, AN, 2021) |
| "Hyperuricemia was significantly associated with increased on-treatment residual ADP-inducible platelet reactivity in clopidogrel- and prasugrel-treated patients in univariate analyses and after adjustment for differences in patient characteristics by multivariate regression analyses." | 4.02 | Decreased Platelet Inhibition by Thienopyridines in Hyperuricemia. ( Gremmel, T; Hoberstorfer, T; Kopp, CW; Lee, S; Panzer, S; Pultar, J; Wadowski, PP; Weikert, C, 2021) |
| "The prognostic value of serum uric acid (SUA) for incident acute coronary syndrome (ACS) in hypertensive subjects is uncertain." | 3.96 | J-shaped association between serum uric acid and acute coronary syndrome in patients with essential hypertension. ( Chen, CL; Feng, YQ; Huang, JY; Huang, YQ; Liu, L; Shen, G; Yu, YL; Zhang, B, 2020) |
| "To investigate the correlation between uric acid (UA) and N-terminal pro-brain natriuretic peptide (NT-proBNP) levels and coronary artery severity in acute coronary syndrome patients of different sexes." | 3.96 | Sex differences in uric acid and NT-pro BNP assessments during coronary severity. ( Chen, X; Guo, G; Huang, Z; Wang, S, 2020) |
| "To assess the association between admission serum uric acid (SUA) levels and in-hospital outcomes in a real-world patients population with acute coronary syndrome (ACS) and to investigate the potential incremental prognostic value of SUA added to GRACE score (GRACE-SUA score)." | 3.96 | Impact of admission serum acid uric levels on in-hospital outcomes in patients with acute coronary syndrome. ( Carugo, S; Castini, D; Centola, M; Ferrante, G; Giannattasio, C; Lucreziotti, S; Mafrici, A; Maloberti, A; Morici, N; Oliva, F; Persampieri, S; Rebora, P; Sabatelli, L; Sacco, A, 2020) |
| "Serum uric acid (SUA) level is known to have a prognostic value in patients with acute coronary syndrome (ACS)." | 3.91 | Relation of Elevated Serum Uric Acid Level to Endothelial Dysfunction in Patients with Acute Coronary Syndrome. ( Fujimoto, Y; Kitahara, H; Kobayashi, Y; Nakayama, T; Saito, Y, 2019) |
| "Elevated serum uric acid (SUA) level is known to be a prognostic factor in patients with acute coronary syndrome (ACS)." | 3.88 | Correlation of Serum Uric Acid Levels with Nonculprit Plaque Instability in Patients with Acute Coronary Syndromes: A 3-Vessel Optical Coherence Tomography Study. ( Lin, L; Wang, N; Yu, B; Zhang, D; Zhang, R, 2018) |
| "The role of serum uric acid in coronary artery disease has been extensively investigated." | 3.88 | Uric acid levels are associated with endothelial dysfunction and severity of coronary atherosclerosis during a first episode of acute coronary syndrome. ( Alessandrini, M; Barraud, J; Bonello, L; Cautela, J; Fenouillet, E; Fromonot, J; Gaubert, M; Guieu, R; Laine, M; Marlinge, M; Mottola, G; Paganelli, F; Rossi, P; Ruf, J; Thuny, F, 2018) |
| "Many studies have reported the independent association between uric acid and cardiovascular disease, its role as a risk predictor for outcomes in people with acute coronary syndrome remains controversial." | 3.88 | Hyperuricemia as a prognostic factor after acute coronary syndrome. ( Bertomeu-Gonzalez, V; Bertomeu-Martinez, V; Carratala-Munuera, C; Cordero, A; Gil-Guillen, VF; Lopez-Pineda, A; Orozco-Beltran, D; Quesada, JA, 2018) |
| "Serum uric acid differentiates AIM and UAP patients in hyperuricemic group of acute coronary syndrome." | 3.85 | Serum Uric Acid Could Differentiate Acute Myocardial Infarction and Unstable Angina Pectoris in Hyperuricemic Acute Coronary Syndrome Patients. ( Hasic, S; Jadric, R; Kadic, D; Kiseljakovic, E; Spahic, E, 2017) |
| "Studies have suggested a relationship between higher baseline serum uric acid (sUA) levels and an elevated risk of subsequent ischemic cardiovascular outcomes among acute coronary syndrome (ACS) patients; this relationship may be modified by a clinical history of gout and has not been studied in large patient cohorts." | 3.85 | An examination of the relationship between serum uric acid level, a clinical history of gout, and cardiovascular outcomes among patients with acute coronary syndrome. ( Akerblom, A; Clare, RM; Held, C; Hess, CN; James, S; Keenan, RT; Klein, AB; Mahaffey, KW; Pagidipati, NJ; Roe, MT; Tricoci, P; Wallentin, L; Wojdyla, D, 2017) |
| " Cox regression analysis showed that the baseline clinical and biochemical variables which associated with MACE were age, being illiterate, a widow or widower, and/or economically dependent, having triple vessel disease, stent implantation, anemia, and/or diabetes mellitus, waist to hip ratio (WHR), diastolic blood pressure, fasting glucose, total cholesterol, high-density lipoprotein cholesterol (HDL-C), creatinine, estimated glomerular filtration rate (eGFR), red blood cell count, hemoglobin, hematocrit, and mean corpuscular-hemoglobin concentration (MCHC) in ACS patients, and age, malnourished, and/or economically dependent, taking hypoglycemic medication, having triple vessel disease, stent implantation, anemia, diabetes mellitus, and/or hypertension, WHR, fasting glucose, HDL-C, uric acid, creatinine, eGFR, high-sensitivity C-reactive protein, mean corpuscular volume, and MCHC in elective PCI patients." | 3.85 | The burden of major adverse cardiac events in patients with coronary artery disease. ( Chung, FM; Hsu, CC; Hung, WC; Lee, YJ; Lu, LF; Lu, YC; Tsai, IT; Wang, CP; Wu, CC; Yu, TH, 2017) |
| "New antithrombotic therapies have significantly improved the outcomes of patients with acute coronary syndrome (ACS), where the introduction of ticagrelor has provided the greatest mortality benefits." | 3.83 | Serum uric acid levels during dual antiplatelet therapy with ticagrelor or clopidogrel: Results from a single-centre study. ( Barbieri, L; Bellomo, G; De Luca, G; Marino, P; Nardin, M; Pergolini, P; Rolla, R; Schaffer, A; Suryapranata, H; Verdoia, M, 2016) |
| "We evaluated uric acid (UA) and high-sensitivity C-reactive protein (hs-CRP) levels in different clinical types of acute coronary syndromes (ACS) and in relationship with the severity of coronary artery lesions." | 3.83 | Study on the levels of uric acid and high-sensitivity C-reactive protein in ACS patients and their relationships with the extent of the coronary artery lesion. ( Fu, Q; Li, XD; Liu, L; Ma, QQ; Wei, P; Yang, NQ; Yang, XJ; Zhu, K, 2016) |
| "Although aspirin-clopidogrel combination is more useful for acute coronary syndrome (ACS), the renal safety of this combination had not been established." | 3.83 | Short Communication: Evaluation of nephrotoxicity by aspirin-clopidogrel combination therapy in patients with acute coronary syndrome. ( Baber, M; HamidAkash, MS; Hussain, SB; Irfan, M; Qadir, MI; Rehman, A, 2016) |
| "To assess serum levels and correlation between uric acid (UA) and C-reactive protein (CRP) in acute coronary syndrome (ACS) and apparently healthy individuals." | 3.81 | Positive correlation between uric acid and C-reactive protein serum level in healthy individuals and patients with acute coronary syndromes. ( Hasić, S; Kiseljaković, E; Kulić, M; Resić, H; Spahić, E, 2015) |
| "Elevated serum uric acid (SUA) level is known to be a prognostic factor in patients with acute coronary syndrome (ACS)." | 3.81 | Relation of Lipid Content of Coronary Plaque to Level of Serum Uric Acid. ( Fujimoto, Y; Kobayashi, Y; Nakayama, T; Saito, Y; Sugimoto, K, 2015) |
| "We evaluated the association of serum uric acid (SUA) level and development of coronary collateral vessels (CCVs) in patients with acute coronary syndrome (ACS)." | 3.78 | High levels of serum uric acid impair development of coronary collaterals in patients with acute coronary syndrome. ( Demircelik, MB; Doger, C; Duran, M; Murat, SN; Ocak, A; Ornek, E; Turfan, M; Vatankulu, MA; Yalcin, AA, 2012) |
| "We aimed to elucidate the relation between serum uric acid (SUA) level and severity of coronary artery disease (CAD) in nondiabetic, nonhypertensive patients (n = 246) with acute coronary syndrome (ACS)." | 3.78 | High levels of serum uric acid predict severity of coronary artery disease in patients with acute coronary syndrome. ( Akpek, M; Duran, M; Elcik, D; Ergin, A; Eryol, NK; Inanc, MT; Kalay, N; Kasapkara, HA; Kaya, MG; Ocak, A; Oguzhan, A; Orscelik, O, 2012) |
| "Uric acid was negatively correlated with minimum arterial oxygen saturation and mean arterial oxygen saturation, and positively correlated with apnea-hypopnea index, oxygen desaturation index and the duration of time with arterial oxygen saturation < 90% (p < 0." | 1.91 | Clinical outcomes of obstructive sleep apnea in patients with acute coronary syndrome in relation to hyperuricemia status. ( Ai, H; Fan, J; Gong, W; Li, S; Nie, S; Que, B; Wang, G; Wang, X; Yan, Y; Zhang, Z; Zhao, X, 2023) |
| "This disorder is correlated to a systemic inflammatory response and some biochemical factors." | 1.91 | C-reactive protein and uric acid roles in distinguishing ST-segment elevation myocardial infarction from non-ST-elevation acute coronary syndrome. ( Ghadakkar, N; Golabchi, A; Motedayyen, H; Zamani, B, 2023) |
| "Hyperuricemia was shown to be an independent risk factor for CAD severity in young adults with ACS (18-35 years of age)." | 1.51 | Hyperuricemia and severity of coronary artery disease: An observational study in adults 35 years of age and younger with acute coronary syndrome. ( Alhelal, JW; Liu, W; Liu, X; Liu, Y; Lv, S; Ravuru, KSS; Shi, D; Zhao, Y; Zhou, Y, 2019) |
| "Gout was defined by self-report, use of urate-lowering therapy, or use of colchicine with evidence of gout on review of the medical record." | 1.51 | Associations of Gout and Baseline Serum Urate Level With Cardiovascular Outcomes: Analysis of the Coronary Disease Cohort Study. ( Doughty, RN; Drake, J; Frampton, C; Richards, AM; Stamp, LK; Troughton, RW, 2019) |
| "Hyperuricemia was present in 356 (29." | 1.48 | Uric acid is associated with long-term adverse cardiovascular outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention. ( Farhan, S; Freynhofer, MK; Hauser, C; Herman, R; Huber, K; Rohla, M; Tscharre, M; Weiss, TW, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (3.08) | 29.6817 |
| 2010's | 39 (60.00) | 24.3611 |
| 2020's | 24 (36.92) | 2.80 |
| Authors | Studies |
|---|---|
| Jiao, Y | 1 |
| Wang, J | 1 |
| Yang, X | 2 |
| Shen, M | 2 |
| Xue, H | 2 |
| Guo, J | 2 |
| Dong, W | 2 |
| Chen, Y | 2 |
| Xi, Q | 1 |
| Fu, Z | 2 |
| Zhang, S | 1 |
| Liu, X | 2 |
| Song, B | 1 |
| Yu, H | 1 |
| Zhang, X | 1 |
| Shao, Y | 1 |
| Rebora, P | 2 |
| Centola, M | 2 |
| Morici, N | 2 |
| Sacco, A | 2 |
| Occhino, G | 1 |
| Viola, G | 1 |
| Oreglia, J | 1 |
| Castini, D | 2 |
| Persampieri, S | 2 |
| Sabatelli, L | 2 |
| Ferrante, G | 2 |
| Lucreziotti, S | 2 |
| Carugo, S | 2 |
| Valsecchi, MG | 1 |
| Oliva, F | 2 |
| Giannattasio, C | 3 |
| Maloberti, A | 3 |
| Abdul Khaliq, SM | 1 |
| Al-Sharifi, AN | 1 |
| Mengozzi, A | 2 |
| Virdis, A | 2 |
| Nakahashi, T | 1 |
| Tada, H | 1 |
| Sakata, K | 1 |
| Yoshida, T | 1 |
| Tanaka, Y | 1 |
| Nomura, A | 1 |
| Terai, H | 1 |
| Horita, Y | 1 |
| Ikeda, M | 1 |
| Namura, M | 1 |
| Takamura, M | 1 |
| Kawashiri, MA | 1 |
| Zamani, B | 1 |
| Golabchi, A | 1 |
| Ghadakkar, N | 1 |
| Motedayyen, H | 1 |
| Li, J | 1 |
| Yang, J | 1 |
| Yu, Q | 1 |
| Chen, L | 2 |
| Shi, X | 1 |
| Su, J | 1 |
| Zhu, K | 2 |
| Chu, X | 1 |
| Lu, Y | 1 |
| Mei, M | 1 |
| Peng, P | 1 |
| Zhao, Y | 2 |
| Fu, G | 1 |
| Qiu, F | 1 |
| Jin, C | 1 |
| Moshkovits, Y | 3 |
| Tiosano, S | 3 |
| Kaplan, A | 3 |
| Kalstein, M | 3 |
| Bayshtok, G | 3 |
| Kivity, S | 3 |
| Segev, S | 3 |
| Grossman, E | 3 |
| Segev, A | 3 |
| Maor, E | 3 |
| Fardman, A | 3 |
| Khameneh Bagheri, R | 3 |
| Najafi, MN | 3 |
| Ahmadi, M | 3 |
| Saberi, M | 3 |
| Maleki, M | 3 |
| Baradaran Rahimi, V | 3 |
| Sun, G | 1 |
| Liu, Y | 2 |
| Rong, D | 1 |
| Liang, X | 1 |
| Jiang, Y | 1 |
| Cai, W | 1 |
| Cai, G | 1 |
| Wang, D | 1 |
| Wu, Q | 2 |
| Zhao, X | 1 |
| Li, S | 1 |
| Wang, X | 2 |
| Fan, J | 1 |
| Ai, H | 1 |
| Que, B | 1 |
| Yan, Y | 1 |
| Zhang, Z | 1 |
| Wang, G | 1 |
| Gong, W | 1 |
| Nie, S | 1 |
| Cimmino, G | 1 |
| Gallinoro, E | 1 |
| di Serafino, L | 1 |
| De Rosa, G | 1 |
| Sugraliyev, A | 1 |
| Golino, P | 1 |
| Cirillo, P | 2 |
| Russo, E | 1 |
| Cicero, AFG | 2 |
| Angeli, F | 1 |
| Agabiti Rosei, E | 1 |
| Barbagallo, CM | 1 |
| Bernardino, B | 1 |
| Bombelli, M | 1 |
| Cappelli, F | 1 |
| Casiglia, E | 1 |
| Cianci, R | 1 |
| Ciccarelli, M | 1 |
| Cirillo, M | 1 |
| Desideri, G | 1 |
| D'Elia, L | 1 |
| Dell'Oro, R | 1 |
| Facchetti, R | 1 |
| Ferri, C | 1 |
| Galletti, F | 1 |
| Gesualdo, L | 1 |
| Iaccarino, G | 1 |
| Lippa, L | 1 |
| Mallamaci, F | 1 |
| Masi, S | 1 |
| Masulli, M | 1 |
| Mazza, A | 1 |
| Muiesan, ML | 1 |
| Nazzaro, P | 1 |
| Parati, G | 1 |
| Palatini, P | 1 |
| Pauletto, P | 1 |
| Pontremoli, R | 1 |
| Pugliese, NR | 1 |
| Quarti-Trevano, F | 1 |
| Rattazzi, M | 1 |
| Reboldi, G | 1 |
| Rivasi, G | 1 |
| Salvetti, M | 1 |
| Tikhonoff, V | 1 |
| Tocci, G | 1 |
| Ungar, A | 1 |
| Verdecchia, P | 1 |
| Viazzi, F | 1 |
| Volpe, M | 1 |
| Grassi, G | 1 |
| Borghi, C | 2 |
| Shen, G | 1 |
| Huang, JY | 1 |
| Yu, YL | 1 |
| Liu, L | 2 |
| Chen, CL | 1 |
| Zhang, B | 1 |
| Huang, YQ | 1 |
| Feng, YQ | 1 |
| Yildirim, E | 1 |
| Ermis, E | 1 |
| Cengiz, M | 1 |
| Lyu, J | 1 |
| Li, Z | 1 |
| Wei, H | 1 |
| Liu, D | 1 |
| Chi, X | 1 |
| Gong, DW | 1 |
| Zhao, Q | 1 |
| Guo, G | 1 |
| Huang, Z | 1 |
| Wang, S | 1 |
| Chen, X | 1 |
| Mafrici, A | 1 |
| Lee, S | 1 |
| Wadowski, PP | 1 |
| Hoberstorfer, T | 1 |
| Weikert, C | 1 |
| Pultar, J | 1 |
| Kopp, CW | 1 |
| Panzer, S | 1 |
| Gremmel, T | 1 |
| Ito, H | 1 |
| Xiao, S | 1 |
| Zhang, L | 1 |
| Hu, Y | 1 |
| Pan, Q | 1 |
| Liu, A | 1 |
| Liu, Q | 1 |
| Liu, J | 1 |
| Zhu, H | 1 |
| Zhou, Y | 3 |
| Pan, D | 1 |
| Qadir, MI | 1 |
| Rehman, A | 1 |
| HamidAkash, MS | 1 |
| Irfan, M | 1 |
| Baber, M | 1 |
| Hussain, SB | 1 |
| Pagidipati, NJ | 1 |
| Hess, CN | 1 |
| Clare, RM | 1 |
| Akerblom, A | 1 |
| Tricoci, P | 1 |
| Wojdyla, D | 1 |
| Keenan, RT | 1 |
| James, S | 1 |
| Held, C | 1 |
| Mahaffey, KW | 1 |
| Klein, AB | 1 |
| Wallentin, L | 1 |
| Roe, MT | 1 |
| Magnoni, M | 2 |
| Berteotti, M | 1 |
| Ceriotti, F | 1 |
| Mallia, V | 1 |
| Vergani, V | 1 |
| Peretto, G | 1 |
| Angeloni, G | 1 |
| Cristell, N | 1 |
| Maseri, A | 1 |
| Cianflone, D | 2 |
| Hasic, S | 2 |
| Kadic, D | 1 |
| Kiseljakovic, E | 2 |
| Jadric, R | 1 |
| Spahic, E | 2 |
| Berezin, AE | 1 |
| Lopez-Pineda, A | 2 |
| Cordero, A | 2 |
| Carratala-Munuera, C | 1 |
| Orozco-Beltran, D | 1 |
| Quesada, JA | 1 |
| Bertomeu-Gonzalez, V | 1 |
| Gil-Guillen, VF | 1 |
| Bertomeu-Martinez, V | 2 |
| Tscharre, M | 1 |
| Herman, R | 1 |
| Rohla, M | 1 |
| Hauser, C | 1 |
| Farhan, S | 1 |
| Freynhofer, MK | 1 |
| Huber, K | 1 |
| Weiss, TW | 1 |
| Tanriverdi, Z | 1 |
| Besli, F | 1 |
| Gungoren, F | 1 |
| Altiparmak, İH | 1 |
| Yesilay, AB | 1 |
| Lv, S | 2 |
| Liu, W | 1 |
| Shi, D | 1 |
| Alhelal, JW | 1 |
| Ravuru, KSS | 1 |
| Zhang, D | 1 |
| Zhang, R | 1 |
| Wang, N | 1 |
| Lin, L | 1 |
| Yu, B | 1 |
| Gaubert, M | 1 |
| Marlinge, M | 1 |
| Alessandrini, M | 1 |
| Laine, M | 1 |
| Bonello, L | 1 |
| Fromonot, J | 1 |
| Cautela, J | 1 |
| Thuny, F | 1 |
| Barraud, J | 1 |
| Mottola, G | 1 |
| Rossi, P | 1 |
| Fenouillet, E | 1 |
| Ruf, J | 1 |
| Guieu, R | 1 |
| Paganelli, F | 1 |
| Saito, Y | 2 |
| Kitahara, H | 1 |
| Nakayama, T | 2 |
| Fujimoto, Y | 2 |
| Kobayashi, Y | 2 |
| Tian, TT | 1 |
| Li, H | 1 |
| Chen, SJ | 1 |
| Wang, Q | 1 |
| Tian, QW | 1 |
| Zhang, BB | 1 |
| Zhu, J | 1 |
| He, GW | 1 |
| Lun, LM | 1 |
| Xuan, C | 1 |
| Ohene, BE | 1 |
| Stamp, LK | 1 |
| Frampton, C | 1 |
| Drake, J | 1 |
| Doughty, RN | 1 |
| Troughton, RW | 1 |
| Richards, AM | 1 |
| Hsu, PC | 1 |
| Su, HM | 1 |
| Lin, TH | 1 |
| Duran, M | 4 |
| Murat, SN | 3 |
| Ornek, E | 3 |
| Wolfenden, TP | 1 |
| Jackson, J | 1 |
| Michels, G | 1 |
| Bunck, AC | 1 |
| Pfister, R | 1 |
| Hung, SF | 1 |
| Huang, CY | 1 |
| Lin, CL | 1 |
| Chung, SD | 1 |
| Chung, CJ | 1 |
| Kao, CH | 1 |
| Chang, CH | 1 |
| Kurtul, A | 1 |
| Yarlioglues, M | 2 |
| Celik, İE | 1 |
| Demircelik, MB | 2 |
| Ocek, AH | 1 |
| Ergun, G | 1 |
| Cetin, M | 1 |
| Kawabe, M | 1 |
| Sato, A | 1 |
| Hoshi, T | 1 |
| Sakai, S | 1 |
| Hiraya, D | 1 |
| Watabe, H | 1 |
| Kakefuda, Y | 1 |
| Ishibashi, M | 1 |
| Abe, D | 1 |
| Takeyasu, N | 1 |
| Aonuma, K | 1 |
| Resić, H | 1 |
| Kulić, M | 1 |
| Sugimoto, K | 1 |
| Qian, G | 1 |
| Aşkın, L | 1 |
| Karakelleoğlu, Ş | 1 |
| Değirmenci, H | 1 |
| Demirelli, S | 1 |
| Şimşek, Z | 1 |
| Taş, MH | 1 |
| Topçu, S | 1 |
| Lazoğlu, Z | 1 |
| Karim, B | 1 |
| Nasution, SA | 1 |
| Wijaya, IP | 1 |
| Harimurti, K | 1 |
| Nardin, M | 1 |
| Verdoia, M | 1 |
| Pergolini, P | 1 |
| Rolla, R | 1 |
| Barbieri, L | 1 |
| Schaffer, A | 1 |
| Marino, P | 1 |
| Bellomo, G | 1 |
| Suryapranata, H | 1 |
| De Luca, G | 1 |
| Ma, QQ | 1 |
| Yang, XJ | 1 |
| Yang, NQ | 1 |
| Li, XD | 1 |
| Fu, Q | 1 |
| Wei, P | 1 |
| Jin, H | 1 |
| Greenslade, JH | 1 |
| Parsonage, WA | 1 |
| Hawkins, T | 1 |
| Than, M | 1 |
| Cullen, L | 1 |
| Tsai, IT | 1 |
| Wang, CP | 1 |
| Lu, YC | 1 |
| Hung, WC | 1 |
| Wu, CC | 1 |
| Lu, LF | 1 |
| Chung, FM | 1 |
| Hsu, CC | 1 |
| Lee, YJ | 1 |
| Yu, TH | 1 |
| Lippi, G | 1 |
| Montagnana, M | 1 |
| Franchini, M | 1 |
| Guidi, GC | 1 |
| Targher, G | 1 |
| Turfan, M | 1 |
| Vatankulu, MA | 1 |
| Ocak, A | 2 |
| Doger, C | 1 |
| Yalcin, AA | 1 |
| Kalay, N | 1 |
| Akpek, M | 2 |
| Orscelik, O | 1 |
| Elcik, D | 1 |
| Inanc, MT | 1 |
| Kasapkara, HA | 2 |
| Oguzhan, A | 1 |
| Eryol, NK | 1 |
| Ergin, A | 1 |
| Kaya, MG | 2 |
| Ndrepepa, G | 1 |
| Braun, S | 1 |
| Haase, HU | 1 |
| Schulz, S | 1 |
| Ranftl, S | 1 |
| Hadamitzky, M | 1 |
| Mehilli, J | 1 |
| Schömig, A | 1 |
| Kastrati, A | 1 |
| Sen, T | 1 |
| Aksu, T | 1 |
| Topsakal, R | 1 |
| Yarlioglues, G | 1 |
| Dogdu, O | 1 |
| Ardic, I | 1 |
| Wang, ZL | 1 |
| Zhao, YQ | 1 |
| Liao, JD | 1 |
| He, JC | 1 |
| Dai, RJ | 1 |
| Shi, SL | 1 |
| Peng, HP | 1 |
| Li, Q | 1 |
1 review available for uric acid and Acute Coronary Syndrome
| Article | Year |
|---|---|
The Results of the URRAH (Uric Acid Right for Heart Health) Project: A Focus on Hyperuricemia in Relation to Cardiovascular and Kidney Disease and its Role in Metabolic Dysregulation.
Topics: Acute Coronary Syndrome; Humans; Hyperuricemia; Kidney Diseases; Metabolic Syndrome; Risk Factors; U | 2023 |
1 trial available for uric acid and Acute Coronary Syndrome
| Article | Year |
|---|---|
Comparison of the effects of metoprolol or carvedilol on serum gamma-glutamyltransferase and uric acid levels among patients with acute coronary syndrome without ST segment elevation.
Topics: Acute Coronary Syndrome; Adrenergic beta-Antagonists; Aged; Carbazoles; Carvedilol; Female; gamma-Gl | 2016 |
63 other studies available for uric acid and Acute Coronary Syndrome
| Article | Year |
|---|---|
Evaluation of the prognostic ability of serum uric acid for elderly acute coronary syndrome patients with diabetes mellitus: a prospective cohort study.
Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Cause of Death; Diabetic Angiopathies; Female; Hum | 2021 |
Impact of serum uric acid levels on the clinical prognosis and severity of coronary artery disease in patients with acute coronary syndrome and hypertension after percutaneous coronary intervention: a prospective cohort study.
Topics: Acute Coronary Syndrome; Coronary Artery Disease; Humans; Hypertension; Percutaneous Coronary Interv | 2022 |
Uric acid associated with acute heart failure presentation in Acute Coronary Syndrome patients.
Topics: Acute Coronary Syndrome; Aged; Cross-Sectional Studies; Female; Heart Failure; Humans; Longitudinal | 2022 |
The effect of serum uric acid in hospitalised patients with acute coronary syndrome in Al-Yarmouk Teaching Hospital.
Topics: Acute Coronary Syndrome; Adolescent; Female; Hospitals, Teaching; Humans; Hyperuricemia; Iraq; Male; | 2021 |
Uric acid and cardiovascular risk stratification in the acute coronary syndromes: a friend we should mind.
Topics: Acute Coronary Syndrome; Cardiovascular Diseases; Friends; Humans; Risk Factors; Uric Acid | 2022 |
The Association Between Serum Uric Acid and Mortality in Patients with Acute Coronary Syndrome After Percutaneous Coronary Intervention.
Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Female; Humans; Male; Middle Aged; Percutaneous Co | 2022 |
C-reactive protein and uric acid roles in distinguishing ST-segment elevation myocardial infarction from non-ST-elevation acute coronary syndrome.
Topics: Acute Coronary Syndrome; C-Reactive Protein; Humans; ST Elevation Myocardial Infarction; Uric Acid | 2023 |
The DNAm levels of CREB5 (cg11301281) were associated with clopidogrel resistance.
Topics: Acute Coronary Syndrome; Albumins; Blood Platelets; Clopidogrel; Cyclic AMP Response Element-Binding | 2022 |
Correlation Between Serum Uric Acid Levels and Coronary Plaque Characteristics on Optical Coherence Tomography.
Topics: Acute Coronary Syndrome; Calcinosis; Coronary Angiography; Coronary Artery Disease; Coronary Vessels | 2022 |
Serum uric acid significantly improves the accuracy of cardiovascular risk score models.
Topics: Acute Coronary Syndrome; Adult; Aged; Aged, 80 and over; Cardiovascular Diseases; Female; Heart Dise | 2023 |
Serum uric acid significantly improves the accuracy of cardiovascular risk score models.
Topics: Acute Coronary Syndrome; Adult; Aged; Aged, 80 and over; Cardiovascular Diseases; Female; Heart Dise | 2023 |
Serum uric acid significantly improves the accuracy of cardiovascular risk score models.
Topics: Acute Coronary Syndrome; Adult; Aged; Aged, 80 and over; Cardiovascular Diseases; Female; Heart Dise | 2023 |
Serum uric acid significantly improves the accuracy of cardiovascular risk score models.
Topics: Acute Coronary Syndrome; Adult; Aged; Aged, 80 and over; Cardiovascular Diseases; Female; Heart Dise | 2023 |
Serum uric acid significantly improves the accuracy of cardiovascular risk score models.
Topics: Acute Coronary Syndrome; Adult; Aged; Aged, 80 and over; Cardiovascular Diseases; Female; Heart Dise | 2023 |
Serum uric acid significantly improves the accuracy of cardiovascular risk score models.
Topics: Acute Coronary Syndrome; Adult; Aged; Aged, 80 and over; Cardiovascular Diseases; Female; Heart Dise | 2023 |
Serum uric acid significantly improves the accuracy of cardiovascular risk score models.
Topics: Acute Coronary Syndrome; Adult; Aged; Aged, 80 and over; Cardiovascular Diseases; Female; Heart Dise | 2023 |
Serum uric acid significantly improves the accuracy of cardiovascular risk score models.
Topics: Acute Coronary Syndrome; Adult; Aged; Aged, 80 and over; Cardiovascular Diseases; Female; Heart Dise | 2023 |
Serum uric acid significantly improves the accuracy of cardiovascular risk score models.
Topics: Acute Coronary Syndrome; Adult; Aged; Aged, 80 and over; Cardiovascular Diseases; Female; Heart Dise | 2023 |
Investigation of the association between serum uric acid levels and HEART risk score in patients with acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aged; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Prognosis | 2022 |
Investigation of the association between serum uric acid levels and HEART risk score in patients with acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aged; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Prognosis | 2022 |
Investigation of the association between serum uric acid levels and HEART risk score in patients with acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aged; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Prognosis | 2022 |
Investigation of the association between serum uric acid levels and HEART risk score in patients with acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aged; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Prognosis | 2022 |
Investigation of the association between serum uric acid levels and HEART risk score in patients with acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aged; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Prognosis | 2022 |
Investigation of the association between serum uric acid levels and HEART risk score in patients with acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aged; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Prognosis | 2022 |
Investigation of the association between serum uric acid levels and HEART risk score in patients with acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aged; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Prognosis | 2022 |
Investigation of the association between serum uric acid levels and HEART risk score in patients with acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aged; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Prognosis | 2022 |
Investigation of the association between serum uric acid levels and HEART risk score in patients with acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aged; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Prognosis | 2022 |
Association between serum uric acid levels and the prevalence of heart failure due to acute coronary syndrome in Chinese hospitalized patients: A cross-sectional study.
Topics: Acute Coronary Syndrome; Cross-Sectional Studies; East Asian People; Heart Failure; Humans; Prevalen | 2023 |
The dysregulation of plasma miR-497/FGF23 axis, and its association with clinical characteristics and major adverse cardiovascular event in female premature acute coronary syndrome patients.
Topics: Acute Coronary Syndrome; Cholesterol; Female; Fibroblast Growth Factor-23; Humans; MicroRNAs; Progno | 2023 |
Clinical outcomes of obstructive sleep apnea in patients with acute coronary syndrome in relation to hyperuricemia status.
Topics: Acute Coronary Syndrome; Humans; Prospective Studies; Risk Factors; Sleep Apnea, Obstructive; Uric A | 2023 |
Uric acid plasma levels are associated with C-reactive protein concentrations and the extent of coronary artery lesions in patients with acute coronary syndromes.
Topics: Acute Coronary Syndrome; Biomarkers; C-Reactive Protein; Coronary Artery Disease; COVID-19; Endothel | 2023 |
J-shaped association between serum uric acid and acute coronary syndrome in patients with essential hypertension.
Topics: Acute Coronary Syndrome; Aged; China; Essential Hypertension; Female; Humans; Hyperuricemia; Longitu | 2020 |
Inflammatory markers of contrast-induced nephropathy in patients with acute coronary syndrome.
Topics: Acute Coronary Syndrome; Acute Kidney Injury; Aged; C-Reactive Protein; Contrast Media; Coronary Ang | 2020 |
A potent risk model for predicting new-onset acute coronary syndrome in patients with type 2 diabetes mellitus in Northwest China.
Topics: Acute Coronary Syndrome; Aged; Biomarkers; Blood Pressure; Body Mass Index; China; Cholesterol, LDL; | 2020 |
Sex differences in uric acid and NT-pro BNP assessments during coronary severity.
Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Biomarkers; Coronary Angiography; Coronary Artery | 2020 |
Impact of admission serum acid uric levels on in-hospital outcomes in patients with acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aged; Female; Hospitals; Humans; Italy; Male; Middle Aged; Prognosis; Retro | 2020 |
Decreased Platelet Inhibition by Thienopyridines in Hyperuricemia.
Topics: Acute Coronary Syndrome; Adenosine Diphosphate; Aged; Angioplasty; Clopidogrel; Comorbidity; Cytochr | 2021 |
Serum uric acid levels: A surrogate marker of oxidative stress or dehydration?
Topics: Acute Coronary Syndrome; Biomarkers; Dehydration; Hospitals; Humans; Oxidative Stress; Uric Acid | 2021 |
Development and Validation of a Risk Nomogram Model for Predicting Revascularization After Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome.
Topics: Acute Coronary Syndrome; Humans; Nomograms; Percutaneous Coronary Intervention; Retrospective Studie | 2021 |
Short Communication: Evaluation of nephrotoxicity by aspirin-clopidogrel combination therapy in patients with acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aspirin; Biomarkers; Blood Urea Nitrogen; Clopidogrel; Creatinine; Drug The | 2016 |
An examination of the relationship between serum uric acid level, a clinical history of gout, and cardiovascular outcomes among patients with acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aged; Cardiovascular Diseases; Cause of Death; Female; Gout; Humans; Male; | 2017 |
Serum uric acid on admission predicts in-hospital mortality in patients with acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aged; Biomarkers; Female; Follow-Up Studies; Hospital Mortality; Humans; Ma | 2017 |
Serum Uric Acid Could Differentiate Acute Myocardial Infarction and Unstable Angina Pectoris in Hyperuricemic Acute Coronary Syndrome Patients.
Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Angina, Unstable; Diagnosis, Differential; Female; | 2017 |
Serum uric acid and acute coronary syndrome: Is there a role for functional markers of residual cardiovascular risk?
Topics: Acute Coronary Syndrome; Biomarkers; Cardiovascular Diseases; Humans; Risk Factors; Uric Acid | 2018 |
Is serum uric acid a pretty accurate prognostic predictor of ST elevated acute coronary syndrome?
Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Humans; Myocardial Infarction; Prognosis; U | 2018 |
Hyperuricemia as a prognostic factor after acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Biomarkers; Decision Support Techniques; Female; H | 2018 |
Uric acid is associated with long-term adverse cardiovascular outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
Topics: Acute Coronary Syndrome; Aged; Biomarkers; Female; Humans; Hyperuricemia; Male; Middle Aged; Percuta | 2018 |
Determination of the optimal cut-off value of serum uric acid concentration in patients with acute coronary syndrome.
Topics: Acute Coronary Syndrome; Humans; Hyperuricemia; Prognosis; Uric Acid | 2018 |
Hyperuricemia and severity of coronary artery disease: An observational study in adults 35 years of age and younger with acute coronary syndrome.
Topics: Acute Coronary Syndrome; Adolescent; Adult; Age Factors; Biomarkers; China; Coronary Artery Disease; | 2019 |
Reply to: "Determination of the optimal cut-off value of serum uric acid concentration in patients with acute coronary syndrome".
Topics: Acute Coronary Syndrome; Humans; Hyperuricemia; Prognosis; Risk Factors; Uric Acid | 2018 |
Correlation of Serum Uric Acid Levels with Nonculprit Plaque Instability in Patients with Acute Coronary Syndromes: A 3-Vessel Optical Coherence Tomography Study.
Topics: Acute Coronary Syndrome; Aged; Coronary Vessels; Female; Humans; Lipids; Macrophages; Male; Middle A | 2018 |
Reply to: Is serum uric acid a pretty accurate prognostic predictor of ST elevated acute coronary syndrome? Author: Alexander E. Berezin.
Topics: Acute Coronary Syndrome; Biomarkers; Humans; Prognosis; Uric Acid | 2018 |
Uric acid levels are associated with endothelial dysfunction and severity of coronary atherosclerosis during a first episode of acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aged; Biomarkers; Coronary Angiography; Coronary Artery Disease; Endotheliu | 2018 |
Relation of Elevated Serum Uric Acid Level to Endothelial Dysfunction in Patients with Acute Coronary Syndrome.
Topics: Acute Coronary Syndrome; Aged; Biomarkers; Endothelium, Vascular; Female; Follow-Up Studies; Humans; | 2019 |
Serum Uric Acid as an Independent Risk Factor for the Presence and Severity of Early-Onset Coronary Artery Disease: A Case-Control Study.
Topics: Acute Coronary Syndrome; Adult; Age of Onset; Body Weight; Case-Control Studies; Coronary Artery Dis | 2018 |
Very High Serum Uric Acid Levels, Plaque Morphology, and the Acute Coronary Syndrome.
Topics: Acute Coronary Syndrome; Coronary Artery Disease; Humans; Plaque, Atherosclerotic; Tomography, Optic | 2018 |
Associations of Gout and Baseline Serum Urate Level With Cardiovascular Outcomes: Analysis of the Coronary Disease Cohort Study.
Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Cardiovascular Diseases; Coronary Artery Disease; | 2019 |
Association between coronary collaterals and serum uric acid level in Chinese population with acute coronary syndrome.
Topics: Acute Coronary Syndrome; Collateral Circulation; Coronary Circulation; Female; Humans; Hyperuricemia | 2013 |
Does serum uric acid level affect coronary collaterals in patients with acute coronary syndrome?
Topics: Acute Coronary Syndrome; Collateral Circulation; Coronary Circulation; Female; Humans; Hyperuricemia | 2013 |
An unusual case of gout.
Topics: Acute Coronary Syndrome; Aged; Chest Pain; Diagnosis, Differential; Gout; Humans; Knee Joint; Male; | 2014 |
[82-year-old man with acute coronary syndrome and unclear arthropathy].
Topics: Absorptiometry, Photon; Acute Coronary Syndrome; Aged, 80 and over; Arthritis, Gouty; Comorbidity; C | 2014 |
Increased risk of acute coronary syndrome among patients with urinary stone disease: a nationwide population-based cohort study.
Topics: Acute Coronary Syndrome; Adult; Age Factors; Aged; Cohort Studies; Diabetes Mellitus; Female; Humans | 2014 |
Predictors of Chronic Total Occlusion in Nonculprit Artery in Patients With Acute Coronary Syndrome: Mean Platelet Volume and Uric Acid.
Topics: Acute Coronary Syndrome; Aged; Biomarkers; Chi-Square Distribution; Chronic Disease; Coronary Angiog | 2015 |
Gender differences in the association between serum uric acid and prognosis in patients with acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aged; Cause of Death; Female; Heart Failure; Humans; Incidence; Kaplan-Meie | 2016 |
Positive correlation between uric acid and C-reactive protein serum level in healthy individuals and patients with acute coronary syndromes.
Topics: Acute Coronary Syndrome; Adult; Aged; Aged, 80 and over; Biomarkers; C-Reactive Protein; Cross-Secti | 2015 |
Relation of Lipid Content of Coronary Plaque to Level of Serum Uric Acid.
Topics: Acute Coronary Syndrome; Aged; Biomarkers; Body Mass Index; Calcinosis; Female; Hospitals, Universit | 2015 |
Hyperhomocysteinemia is an independent predictor of long-term clinical outcomes in Chinese octogenarians with acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aged, 80 and over; Blood Pressure; China; Coronary Angiography; Cystatin C; | 2015 |
Hyperuricemia as a Risk Factors of Major Adverse Cardiac Events in Patients with Acute Coronary Syndrome: a Retrospective Cohort Study.
Topics: Acute Coronary Syndrome; Biomarkers; Coronary Angiography; Electrocardiography; Female; Follow-Up St | 2015 |
Serum uric acid levels during dual antiplatelet therapy with ticagrelor or clopidogrel: Results from a single-centre study.
Topics: Acute Coronary Syndrome; Adenosine; Aged; Aspirin; Biomarkers; Chi-Square Distribution; Clopidogrel; | 2016 |
Study on the levels of uric acid and high-sensitivity C-reactive protein in ACS patients and their relationships with the extent of the coronary artery lesion.
Topics: Acute Coronary Syndrome; Aged; Angina, Unstable; Biomarkers; C-Reactive Protein; Coronary Vessels; F | 2016 |
Does Uric Acid Level Provide Additional Risk Stratification Information in Emergency Patients With Symptoms of Possible Acute Coronary Syndrome?
Topics: Acute Coronary Syndrome; Aged; Biomarkers; Diagnosis, Differential; Electrocardiography; Emergency S | 2016 |
The burden of major adverse cardiac events in patients with coronary artery disease.
Topics: Acute Coronary Syndrome; Adult; Aged; Aged, 80 and over; Area Under Curve; Chi-Square Distribution; | 2017 |
Uric acid concentration in patient with acute coronary syndrome.
Topics: Acute Coronary Syndrome; Biomarkers; Female; Humans; Male; Risk Factors; Troponin T; Uric Acid | 2008 |
High levels of serum uric acid impair development of coronary collaterals in patients with acute coronary syndrome.
Topics: Acute Coronary Syndrome; Biomarkers; Collateral Circulation; Coronary Angiography; Coronary Circulat | 2012 |
High levels of serum uric acid predict severity of coronary artery disease in patients with acute coronary syndrome.
Topics: Acute Coronary Syndrome; Biomarkers; Coronary Angiography; Coronary Artery Disease; Coronary Disease | 2012 |
Prognostic value of uric acid in patients with acute coronary syndromes.
Topics: Acute Coronary Syndrome; Aged; Biomarkers; Cause of Death; Coronary Angiography; Disease Progression | 2012 |
Serum uric acid level as a part of the metabolic syndrome impairs the coronary collateral formation.
Topics: Acute Coronary Syndrome; Collateral Circulation; Coronary Circulation; Female; Humans; Hyperuricemia | 2012 |
Effects of serum uric acid levels on coronary collateral circulation in patients with non-ST elevation acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aged; Biomarkers; Chi-Square Distribution; Collateral Circulation; Coronary | 2012 |
[Association of endothelial nitric oxide synthase gene polymorphism with level of uric acid in serum for acute coronary syndrome].
Topics: Acute Coronary Syndrome; China; Ethnicity; Gene Frequency; Genotype; Humans; Nitric Oxide Synthase T | 2007 |